Moreover, inhibition of CUL3-SPOP E3 ligase impairs ubiquitination-mediated PD-L1 degradation, increasing PD-L1 protein levels and reducing the numbers of tumor-infiltrating lymphocytes in mouse tumors and primary human prostate cancer [87]. Here, CD274 is linked to neoplasm.